HADH may be the target molecule of early vascular endothelial impairment in T2DM

HADH may be the target molecule of early vascular endothelial impairment in T2DM

BackgroundType 2 diabetes mellitus (T2DM) will significantly increase the risk of atherosclerosis (AS). Vascular endothelial cell dysfunction (VECD) is the foundation of AS. Early identification and intervention of VECD caused by T2DM can help us effectively delay or even suppress the occurrence of...

Full description

Bibliographic Details
Main Authors: Haowen Ye, Ruxin Wang, Jinjing Wei, Ying Wang, Lihong Wang, Xiaofang Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
WGCNA
GEO
T2DM
AS
endothelial cell dysfunction
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.963916/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.963916/full

Similar Items